Lgals12−/− mice have increased insulin sensitivity and glucose tolerance, contributing galectin-12 function to diabetes and metabolic syndrome, and indicating the potential involvement in cardiovascular diseases (251). This evidence concerns the gene LGALS12 and cardiovascular disorder.